New combo drug therapy aims to protect hearts after noncardiac surgery
NCT ID NCT06961630
First seen Nov 01, 2025 · Last updated Apr 22, 2026 · Updated 25 times
Summary
This study tests whether giving a blood thinner (rivaroxaban) and a cholesterol-lowering drug (atorvastatin) can reduce heart-related risks in adults who had a heart injury after noncardiac surgery. The study includes 50 people aged 45 or older who recently had major surgery and shows signs of heart muscle damage. The main goal is to see if this approach is practical for a larger future trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDIAL INJURY AFTER NONCARDIAC SURGERY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.